Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A

While the final frontier of Alzheimer’s disease work is patrolled by U.S. Big Pharmas like Eli Lilly and Biogen as well as Japan’s Eisai, the U.K. is sending out its own mission in the form of AstronauTx.